Jefferies Says Buy Neurocrine After Yesterday's 'Unwarranted' Selloff
November 15, 2018 at 10:46 AM EST
Jefferies analyst Biren Amin tells investors to buy shares of Neurocrine Biosciences after hosting a dinner with management.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|